Related Experiment Video
Updated: Apr 23, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
[Mitochondrial neurogastrointestinal encephalopathy disease]
A Benureau1, P Meyer2, O Maillet3
1Service de neuropédiatrie, hôpital Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare genetic disorder. Early MRI is crucial for diagnosing MNGIE in patients with atypical anorexia symptoms, enabling timely nutritional support.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Background:
- Mitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare, autosomal-recessive disorder caused by mutations in the TYMP gene.
- This genetic defect leads to thymidine phosphorylase (TP) deficiency, causing nucleotide pool imbalance and mitochondrial DNA instability.
Observation:
- A case of a 14-year-old female with MNGIE presenting with chronic vomiting, cachexia, and weight loss is detailed.
- Cerebral MRI revealed white matter abnormalities, prompting MNGIE diagnosis in a patient with atypical anorexia symptoms.
Findings:
- MNGIE presents with gastrointestinal dysmotility, cachexia, ptosis, ophthalmoplegia, peripheral neuropathy, and leukoencephalopathy.
- Diagnosis relies on clinical presentation, genetic testing, and neuroimaging, with MRI being key for atypical anorexia cases.
Implications:
- Early diagnosis through MRI in patients with atypical anorexia is vital for initiating supportive care, including nutritional management.
- While no definitive treatment exists, ongoing research offers hope for future therapeutic strategies for MNGIE.
More Related Videos
Related Concept Videos
Hepatic Encephalopathy
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Esophageal Achalasia
Animal Mitochondrial Genetics

